COVID-19 and Hidradenitis Suppurativa
Research regarding HS, COVID-19, and related medications is ongoing as scientists continuously learn more about the disease. The therapies given for HS maysuppressor moderate the immune system. It is an autoinflammatory disease (which means your immune system is overactive) rather than anautoimmune disease. PeopleImages / E+ / Getty Images HS is not considered a specific risk factor for COVID-19. HS is more prevalent among ethnic minorities. This could lead to poorer outcomes....